SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Crypto is trending after a recent price surge ignited a polarized community discussion. Supporters emphasize its real-world utility through Flexa's merchant network and anticipate significant growth with pending regulatory clarity and strategic partnerships. However, many investors express deep frustration, warning of sustained manipulation and a history of pump-and-dump cycles despite its technological foundations.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending as discussions center on its strategic positioning to capitalize on the multi-billion dollar Rural Health Transformation Program and its new TytoCare integration, aiming to expand virtual care in underserved areas. Community sentiment is sharply divided, with many anticipating a significant long-term rebound driven by healthcare reform and AI innovation, while others express deep frustration over past financial performance, leadership decisions, and persistent stock underperformance. The conversation reflects a strong divergence between high conviction in a future turnaround and calls for greater accountability from management.

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

ConocoPhillips is a key focus following its Marathon Oil acquisition, which enhances its low-cost U.S. shale portfolio and is projected to deliver over $1 billion in annual synergies. The community is actively discussing COP's strong Q4 earnings beat, substantial shareholder return commitments, and strategic moves in LNG and Arctic exploration. Investors are weighing these developments against volatile oil prices and geopolitical events, highlighting the company's long-term resilience.

TotalEnergies SE is a global integrated energy company, which engages in the production of oil and biofuels, natural gas and green gases, renewables and electricity. It operates through the following business segments: Exploration & Production, Integrated LNG, Integrated Power, Refining & Chemicals, and Marketing & Services. The Exploration & Production segment encompasses oil and natural gas exploration and production activities. The Integrated LNG segment includes the integrated gas chain (including upstream and midstream LNG activities) as well as biogas, hydrogen and gas trading activities. The Integrated Power segment involves in the generation, storage, electricity trading and B2B-B2C distribution of gas and electricity. The Refining & Chemicals segment engages in the activities of refining, petrochemicals and specialty chemicals. This segment also includes the activities of oil supply, trading and marine shipping. The Marketing & Services segment includes the global activities of supply and marketing in the field of petroleum products. The company was founded on March 28, 1924 and is headquartered in Courbevoie, France.

TotalEnergies SE

Total Energies

TotalEnergies is trending as it expands its clean energy footprint with significant long-term deals, including powering Google's data centers, and actively pursues high-potential deepwater oil and gas exploration projects. The community is discussing its compelling dividend yield and strategic portfolio transformation, alongside its potential consideration for a New York listing to enhance valuation.

Southern Copper Corp. engages in the development, production, and exploration of copper, molybdenum, zinc, and silver. It operates through the following segments: Peruvian Operations, Mexican Open-Pit Operations, and Mexican Underground Mining Operations. The Peruvian Operations segment focuses on the Toquepala and Cuajone mine complexes and the smelting and refining plants, industrial railroad, and port facilities that service both mines. The Mexican Open-Pit Operations segment comprises the La Caridad and Buenavista mine complexes, the smelting, and refining plants and support facilities, which service both mines. The Mexican Underground Mining Operations segment is involved in the operation of five underground mines, a coal mine, and several industrial processing facilities. The company was founded on December 12, 1952 and is headquartered in Phoenix, AZ.

Southern Copper Corporation

Southern Copper is trending as copper prices reach record highs, fueled by tightening global supply and robust demand from electrification and AI data centers. The community is actively discussing how ongoing mine disruptions and strong industrial needs position SCCO as a prime beneficiary in the bullish copper market. Many investors view the metal as the "new gold" amid a burgeoning commodity supercycle.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance (AERO) is trending following its Robinhood listing and ongoing discussions about its Velodrome merger, which aims to establish it as a cross-chain liquidity hub for the expanding Base ecosystem. Despite significant price volatility, the community is actively debating its strong fundamentals, including consistent token buybacks and protocol revenue surpassing emissions, with many viewing AERO as a generational opportunity in the current market.

Parker-Hannifin Corp. engages in the manufacture of motion and control technologies and systems. It operates through the Diversified Industrial and Aerospace Systems segments. The Diversified Industrial segment sells products to both original equipment manufacturers and distributors who serve the replacement markets in manufacturing, packaging, processing, transportation, mobile construction, refrigeration and air conditioning, agricultural and military machinery, and equipment industries. The Aerospace Systems segment offers products primarily in the commercial and military aerospace markets to both OEMs and to end users for spares, maintenance, repair, and overhaul. The company was founded by Arthur L. Parker in 1918 and is headquartered in Cleveland, OH.

Parker-Hannifin Corp.

Parker-Hannifin ($PH) is trending following its strategic acquisition of Filtration Group for over $9 billion, a move anticipated to significantly expand its market leadership and boost future earnings. This major corporate development, combined with continued strong performance in its Aerospace Systems segment and its reputation as a "Dividend King," is fueling bullish analyst sentiment and investor discussion, despite some debates around its current valuation.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is trending after a pipeline setback in acute pain led to a recent dip, despite strong earnings and a robust development portfolio. The community is now actively debating the underappreciated potential of Journavx in pain management and highlighting promising advancements in the company's kidney disease and Type 1 Diabetes programs. Analysts are increasingly optimistic, with several upgrades underscoring confidence in Vertex's diversified growth beyond its dominant cystic fibrosis franchise.

SPDR Series Trust - State Street SPDR S&P Oil & Gas Exploration & Production ETF

SPDR Oil & Gas Exploration & Production ETF

The oil and gas exploration and production sector, represented by XOP, is fueling vigorous community debate, with many investors actively accumulating on perceived dips amidst discussions of a suppressed physical market and surging global demand from emerging economies and data centers. Despite ongoing geopolitical uncertainties and varied economic forecasts, there's a strong contrarian belief that the sector is building towards a significant long-term breakout into the late 2020s.

KKR & Co., Inc. operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities. The Insurance Business segment offers retirement, life insurance and reinsurance solutions to clients across individual and institutional markets. The company was founded by Henry Kravis, George R. Roberts, and Jerome Kholberg on May 1, 1976 and is headquartered in New York, NY.

KKR & Co. Inc

KKR & Co. Inc.

KKR is trending amid its aggressive strategic expansion into high-growth sectors like digital infrastructure, real estate, and healthcare, underpinned by strong capital raising and robust earnings. The firm's continuous deal-making and positive analyst sentiment are fueling investor discussions about its long-term trajectory in alternative asset management. Community chatter highlights KKR's positioning in AI-related infrastructure and its transition to a diversified, permanent capital model, drawing comparisons to leading financial institutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why You Should Build a Global Portfolio With ETFs 

Despite slowing growth, global equities are showing renewed strength. Discover how a globally diversified ETF portfolio can help investors build more balanced, opportunity-ready portfolios.

Should You Look Abroad? Global Equity ETFs to Consider

Stretched U.S. valuations and AI bubble fears have investors looking abroad and are driving interest in international equity and emerging market ETFs.

Don't Go All-In on Tech: Diversify With These ETFs  

As bubble fears rise and volatility spikes, investors can turn to ETFs like RSP, GLD and IEMG to diversify and cut concentration risk.

Feeling Tech-Heavy? Diversify With These ETFs Amid AI Bubble Concerns

Wall Street warns of an AI equity bubble as mega-cap tech surges, prompting investors to diversify into ETFs for balanced growth.

Should Investors Pivot to Global Equity ETFs for Wider Market Exposure?

Investors can eye global equity funds as AI bubble fears, U.S. market risks and Fed easing fuel demand for international diversification.

Danish drugmaker Novo Nordisk (NVO) has reportedly laid off dozens of employees at its largest U.S. manufacturing site, which produces its blockbuster Semaglutide drugs.According to a Reuters <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/world-at-work/novo-nordisk-cuts-hit-production-line-jobs-key-us-plant-posts-show-2025-10-07/">report</a>, citing a review of LinkedIn posts, the job cuts included staff in manufacturing roles, from quality control to production line technicians at Novo’s major Clayton, North Carolina, plant and other facilities in the state. It also includes a strategic communications manager and an HR assistant, the report added.The Clayton facility makes Semaglutide, the active ingredient in the company’s blockbuster Wegovy and Ozempic. It also does steps including filling, finishing, and packaging the injections. It will also play a part in the production of the pill version of Wegovy once available, Reuters noted.Notably, Novo announced layoffs in September and forecast billions in annual savings. The company had said that it would cut 9,000 positions, or about 11.5% of its 78,400-strong global workforce, as part of a company-wide transformation. About 5,000 roles will be eliminated in Denmark, it said.The restructuring is expected to save eight billion Danish crowns ($1.26 billion) annually by 2026 and will focus resources on diabetes and obesity, Novo’s key growth areas. Reuters noted that the exact reason and number for layoffs in Clayton are unclear.Shares of NVO stock fell 1% in the pre-market session at the time of writing. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/NVO">NVO stock</a> stayed within the ‘neutral’ territory over the past 24 hours, and message volume stayed within ‘normal’ levels.<figure class="image"><img style="aspect-ratio:1364/120;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_07_at_7_12_09_AM_png_2205cacccb.webp" alt="NVO's Sentiment Meter and Message Volume as of 7:10 a.m. ET on Oct. 07, 2025 | Source: Stocktwits" width="1364" height="120"><figcaption>NVO's Sentiment Meter and Message Volume as of 7:10 a.m. ET on Oct. 07, 2025 | Source: Stocktwits</figcaption></figure>NVO stock fell 31% this year and by about 49% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/grrr-shares-rally-over-4-percent-pre-market-retail-says-stock-should-be-trading-over-40/ch6PBTQR3Wu">GRRR Shares Rally Over 4% Pre-Market, Retail Says Stock Should Be Trading Over $40: ‘Unbelievable! Way, Way Undervalued’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. 

Novo Nordisk Reportedly Slashes Workforce At Its US Wegovy Manufacturing Plant

According to a Reuters report, the job cuts included staff in manufacturing roles, from quality control to production line technicians at Novo’s major Clayton plant. 

Equity

According to a Reuters report, the job cuts included staff in manufacturing roles, from quality control to production line technicians at Novo’s major Clayton plant. 


Global Equity ETFs Draw Rising Investor Interest

Global equity funds saw $10.65B inflows as Fed rate cut bets, a weak dollar and diversification needs drive investors abroad.

Diversify With ETFs and Stay Ahead in Volatile Markets

Amid AI bubble worries and tech sell-offs, investors turn to value, consumer staples, gold and international ETFs for diversification.

Drugmaker Novo Nordisk (NVO) will offer a reduced 2025 yearly bonus to its employees in Denmark due to the company’s lowered forecast, Bloomberg reported on Friday, citing a company spokesperson.The reduction will apply to employees who are eligible for short-term incentives in Denmark, the report <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-08-22/novo-to-cut-employee-bonuses-in-denmark-due-to-slower-growth?srnd=homepage-americas">added</a>. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/NVO">Novo</a> jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume remained at ‘normal’ levels. Shares of the company traded 3% higher in the pre-market session at the time of writing.<figure class="image"><img style="aspect-ratio:574/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_22_at_8_54_27_AM_png_454a11d7f9.webp" alt="NVO's Sentiment Meter and Message Volume as of 8:50 a.m. ET on Aug. 22, 2025 | Source: Stocktwits" width="574" height="62"><figcaption>NVO's Sentiment Meter and Message Volume as of 8:50 a.m. ET on Aug. 22, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user said that they expect the stock to hit $80 by the end of the year.<stembedurl>https://stocktwits.com/WallstreetPatron43/message/626170781</stembedurl>Another user said that they expect a lot of shorting on Friday.<stembedurl>https://stocktwits.com/oldmanrizzer/message/626170959</stembedurl>Earlier this week, it was <a href="https://stocktwits.com/news-articles/markets/equity/novo-nordisk-freezes-hiring-to-cut-costs-says-report/chsinAURdhO">reported</a> that the drugmaker has implemented a hiring freeze, which will apply across all markets and departments, with an exemption for business-critical roles. Former CEO of Novo Nordisk, Lars Fruergaard Jørgensen, said earlier this month that the company is taking measures to sharpen its commercial execution further, and ensure efficiencies in cost base while continuing to invest in future growth. Novo’s new CEO, Maziar Mike Doustdar, took charge on August 7.Last month, the company, battling competition from its U.S. rival Eli Lilly, lowered its full-year 2025 outlook, citing lower growth expectations for its blockbuster weight loss drug Wegovy and diabetes drug Ozempic for the second half of the year.The firm now expects sales growth of 8% to 14% during the year at a constant exchange rate, down from its previous estimate of 13% to 21%. Operating profit growth is now expected to be 10% to 16%, down from its prior outlook of 16% to 24%.NVO stock is down by 36% this year and by 59% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/jpmorgan-sees-near-50-percent-upside-on-ehang/chsZcIERd0M">JPMorgan Sees Near 50% Upside On This Chinese eVTOL Maker: Retail Believes There’s A Lot To Look Forward To</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Ozempic manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on December 7, 2023. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Novo Nordisk To Reportedly Cut Yearly Bonus For Denmark Employees: Retail Expects Stock To Hit $80 By Year-End

According to Bloomberg, the reduction in bonuses will apply to employees who are eligible for short-term incentives in Denmark.

Retail sentiment around Anheuser-Busch InBev (ABI),&nbsp;the maker of Budweiser and Corona beers, ticked higher, even as a weak quarterly report sent its shares sliding on Thursday.<a href="https://stocktwits.com/symbol/BUD">BUD's U.S.-listed shares</a> dropped over 13%&nbsp;in the previous session, marking their worst day in over five years.On Stocktwits, retail sentiment&nbsp;shifted to 'extremely bullish' by early Friday, up from 'bullish' the day before, as traders&nbsp;viewed the slide as an overreaction and saw it as a buying opportunity. Message volume for BUD rose 1,200% in the past 24-hour period, among the highest for a consumer stock.<figure class="image"><img style="aspect-ratio:1256/156;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_01_at_12_48_05_PM_png_fd95800c98.webp" alt="Screenshot 2025-08-01 at 12.48.05 PM.png" width="1256" height="156"><figcaption>BUD sentiment and message volume as of August 1 | Source: Stocktwits</figcaption></figure>"Not a fan of the company, but this drop is a bit unjustified," said one user<stembedurl>https://stocktwits.com/Reddiot/message/623258303</stembedurl>Another said: "$BUD Buying dat dip, 10% discount? Thank you!" A third user shared a technical chart showing the stock hitting a key long-term support level.<stembedurl>https://stocktwits.com/stocksailor23/message/623228047</stembedurl><stembedurl>https://stocktwits.com/theoptionsplug/message/623173574</stembedurl>AB InBev said revenue grew 3% organically in the second quarter, below market expectations of 3.2% growth. Organic sales volumes, however, were down 1.9%,&nbsp;primarily due to weak sales in Brazil and China, marking the&nbsp;ninth consecutive quarter of declining beer sales.&nbsp;That was significantly below the 0.3% decline analysts had expected.Organic operating profit increased by 6.5%, ahead of analysts' forecasts of 5.7%.The world's largest brewer also reported weaker-than-expected volumes in Europe and the Middle East,&nbsp;which led to disappointment in all regions except North America.A rebound in the home market comes even as beer demand softens in the region. Bank of America has&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bof-a-downgrades-miller-lite-brewer-molson-coors-amid-softness-in-us-beer-sales/chmZESFRReS">predicted</a> that U.S. beer volumes will shrink by 4% next year, steeper than its earlier prediction of 1% decline.In early July, AB InBev&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/budweiser-maker-ab-inbev-plans-300m-investment-to-expand-us-production/chi8fifRbZd">announced</a> plans to invest $300 million in its U.S. manufacturing operations this year, aligning with the Trump administration's broader push for domestic production.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/Starbucks-china-operations-jd-tencent-kkr-among-potential-investors/chr3YU9RdGt">Starbucks China Operations: JD, Tencent, KKR Among Potential Investors To Submit Bids - Report</a>

In this photo illustration, Budweiser beer bottles are seen displayed. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

Budweiser Maker’s Stock Gets Crushed After Q2 Gloom — Retail Traders Feel 'Drop Is A Bit Unjustified'

U.S.-listed shares of the world's largest brewer marked their worst day in over five years after the company missed revenue and volume estimates.

AVDE
American Century ETF Trust - Avantis International Equity ETF

Feed

News

Sentiment

Fundamentals

Info

Latest AVDE News

AVDEAmerican Century ETF Trust - Avantis International Equity ETF